Doubling down against diabetes

Turbo-charged gut hormones

2012-11-13

(Press-News.org) This press release is available in German.

A collaboration between scientists in Munich, Germany and Bloomington, USA may have overcome one of the major challenges drug makers have struggled with for years: Delivering powerful nuclear hormones to specific tissues, while keeping them away from others.

The teams led by physician Matthias Tschöp (Helmholtz Zentrum München, and Technische Universität München) and chemist Richard DiMarchi (Indiana University) used natural gut peptides targeting cell membrane receptors and engineered them to carry small steroids known to act at the cell nucleus. DiMarchi and Tschöp hoped that such "turbo-charged" hormone hybrids would only deliver their steroid inside cells, where their specific peptide receptor was expressed at the surface.

Both teams had been working together for years to discover new ways to treat obesity and diabetes. They therefore started out with the gut hormone glucagon-like peptide-1, which is known to act at pancreas and brain cells to improve insulin secretion, blood glucose, and body weight. They engineered these peptides to reversibly bind the female sex steroid, estrogen, which is also known to confer powerful metabolic benefits at some of the same target cells. In the past, pharmacologists had been unable to utilize such benefits as high doses of systemic estrogen can also powerfully affect reproductive organs and increase cancer risk.

Using their GLP-1/estrogen-conjugates however, DiMarchi and Tschöp found that they were able to multiply metabolic benefits in mice, without apparent side effects on estrogen-sensitive reproductive organs such as the uterus. They also found no impact of their "turbo-charged" gut peptides on growth of estrogen-sensitive tumors. Genetic studies at the same time however uncovered clear estrogen effects in pancreas and brain tissue of mice treated with the new combination drug candidate, indicating that the collaborating teams had indeed succeeded with targeted delivery of steroids.

"Our novel GLP-1/estrogen molecules seem to outperform more traditional therapeutics in mouse models of obesity and type 2 diabetes" says Brian Finan, scientist at the Helmholtz Zentrum München and first author of the study published online in the journal Nature Medicine. "What we are even more excited about" he adds "is the opportunity to use targeted steroid hormone for other diseases, where side effects had prevented therapeutic use in the past. "There is still a lot we don't know about the mechanistic details," cautions Matthias Tschöp, director of the Helmholtz Institute for Diabetes and Obesity "but if they proof safe enough for clinical use, these molecules could offer transformative potential."

### Original publication: Finan B. et al. (2012) Targeted estrogen delivery reverses the metabolic syndrome. Nature Medicine, advances online publication, 11. November 2012. Link zur Fachpublikation: http://www.nature.com/nm/journal/vaop/ncurrent/full/nm.3009.html

Kontakt Prof. Matthias Tschöp
Helmholtz Zentrum München - Deutsches Forschungszentrum für Gesundheit und Umwelt (GmbH)
Institute of Diabetes and Obesity (IDO)
Ingolstädter Landstr. 1
85764 Neuherberg
Tel.: 089-3187-2103
E-Mail: matthias.tschoep@helmholtz-muenchen.de END

ELSE PRESS RELEASES FROM THIS DATE:

New study examines how health affects happiness

2012-11-13

Fairfax, Va., (November 13, 2012) — A new study published in the Journal of Happiness Studies found that the degree to which a disease disrupts daily functioning is associated with reduced happiness. Lead author Erik Angner, associate professor of philosophy, economics and public policy at George Mason University, worked with an interdisciplinary team of researchers from the University of Alabama at Birmingham, the University of Chicago and the University of Massachusetts Medical School. The full study is available at http://www.springerlink.com/content/k5231631755g86g2/?MUD=MP. Previous ...

Advocacy for planned home birth not in patients' best interest

2012-11-13

Philadelphia, PA, November 13, 2012 – Advocates of planned home birth have emphasized its benefits for patient safety, patient satisfaction, cost effectiveness, and respect for women's rights. A clinical opinion paper published in the American Journal of Obstetrics and Gynecology critically evaluates each of these claims in its effort to identify professionally appropriate responses of obstetricians and other concerned physicians to planned home birth. Throughout the United States and Europe, planned home birth has seen increased activity in recent years. Professional ...

Study sheds light on genetic 'clock' in embryonic cells

2012-11-13

As they develop, vertebrate embryos form vertebrae in a sequential, time-controlled way. Scientists have determined previously that this process of body segmentation is controlled by a kind of "clock," regulated by the oscillating activity of certain genes within embryonic cells. But questions remain about how precisely this timing system works. A new international cross-disciplinary collaboration between physicists and molecular genetics researchers advances scientists' understanding of this crucial biological timing system. The study, co-authored by McGill University ...

Underemployment persists since recession, with youngest workers hardest hit

2012-11-13

DURHAM, N.H. – Underemployment has remained persistently high in the aftermath of the Great Recession with workers younger than 30 especially feeling the pinch, according to new research from the Carsey Institute at the University of New Hampshire. "While on the decline, these rates have yet to return to their prerecession levels. Moreover, as the recession and other economic forces keeps older workers in the economy, openings for full-time jobs for younger workers might remain limited in the short-term," said Justin Young, a doctoral student in sociology at UNH and a ...

Edison Pharmaceuticals announces initiation of EPI-743 Phase 2B Leigh Syndrome Clinical Trial

2012-11-13

Mountain View, California; November 13, 2012. Edison Pharmaceuticals today announced the initiation of a phase 2B study entitled, "A Phase 2B Randomized, Placebo-Controlled, Double-Blind Clinical Trial of EPI-743 in Children with Leigh Syndrome." Four clinical trial sites have been selected in the United States: Lucile Packard Children's Hospital, Stanford University Medical Center – Palo Alto, California; Akron Children's Hospital – Akron, Ohio; Seattle Children's Hospital – Seattle, Washington; and Texas Children's Hospital, Baylor University – Houston, Texas. The ...

A sip of resveratrol and a full p53: Ingredients for a successful cell death

2012-11-13

Rio de Janeiro, Brazil- Resveratrol is a naturally occurring dietary compound found in grapes, berries, and peanuts. This polyphenol protects plants against pathogens such as bacteria and fungi by inducing cell death in invading organisms. The compound was discovered in red wine in 1939 but by large did not attract the attention of the scientific community. More recently, pre-clinical studies have revealed the many beneficial properties of resveratrol. These include antidiabetic, cardioprotective, and chemopreventive effects. The latter has been associated to resveratrol ...

Should hyperbaric oxygen therapy be used to treat combat-related mild traumatic brain injury?

2012-11-13

New Rochelle, NY, November 13, 2012—The average incidence of traumatic brain injury (TBI) among service members deployed in Middle East conflict zones has increased 117% in recent years, mainly due to proximity to explosive blasts. Therapeutic exposure to a high oxygen environment was hoped to minimize the concussion symptoms resulting from mild TBI, but hyperbaric oxygen (HBO2) treatment may not offer significant advantages, according to an article in Journal of Neurotrauma, a peer-reviewed journal from Mary Ann Liebert, Inc., publishers. The article is available free ...

Trying to save money? Ask for crisp new bills at the bank

2012-11-13

Consumers will spend more to get rid of worn bills because they evoke feelings of disgust but are more likely to hold on to crisp new currency, according to a new study in the Journal of Consumer Research. "The physical appearance of money can alter spending behavior. Consumers tend to infer that worn bills are used and contaminated, whereas crisp bills give them a sense of pride in owning bills that can be spent around others," write authors Fabrizio Di Muro (University of Winnipeg) and Theodore J. Noseworthy (University of Guelph). Does the physical appearance of ...

CU-NOAA study shows summer climate change, mostly warming

2012-11-13

Analysis of 90 years of observational data has revealed that summer climates in regions across the globe are changing -- mostly, but not always, warming --according to a new study led by a scientist from the Cooperative Institute for Research in Environmental Sciences headquartered at the University of Colorado Boulder. "It is the first time that we show on a local scale that there are significant changes in summer temperatures," said lead author CIRES scientist Irina Mahlstein. "This result shows us that we are experiencing a new summer climate regime in some regions." The ...

Frustrated FATshionistas: How do plus-sized consumers mobilize to demand better clothing options?

2012-11-13

Marginalized groups of consumers can mobilize as an online community to seek greater inclusion in and more choice from mainstream markets, according to a new study in the Journal of Consumer Research. "In order to gain greater inclusion in the mainstream market, fatshionistas have tried to persuade established companies to serve them better, publicized the offerings of companies that have tried meeting their needs, and looked for opportunities to interact with influential designers and retailers in order to influence them to do more to serve their needs," write authors ...

Doubling down against diabetes

ELSE PRESS RELEASES FROM THIS DATE:

LAST 30 PRESS RELEASES: